Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine
Clinical trial NCT04921384 · COMPLETED
Trial details
- NCT number
- NCT04921384
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-29
- Primary completion
- 2024-10-01
- Enrollment
- 981
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.